Mereo Biopharma Group Plc (MREO) - News Archive

London-based clinical-stage biopharmaceutical company, Mereo BioPharma Group plc, has recently disclosed the pricing of its underwritten offering of 12,531,300 American Depositary Shares (ADSs). Priced at $3.99 per ADS,...

Mereo BioPharma, a leading biopharmaceutical company with the chief aim to develop and commercialize innovative therapeutics, has recently provided an update on its formidable pipeline progress and corporate development...